Replies to post #8160 on PharmaCyte Biotech Inc (PMCB)

[DITRstocks]

Drugs that can achieve “breakthrough” status will have the FDA’s attention. “We expect many of these would come available very quickly with Phase I data.” - Janet Woodcock

NVLX